- Oral presentation
- Open Access
Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients
Clinical and Translational Allergy volume 4, Article number: O1 (2014)
Background / Objective
Prior use of "lymphocyte transformation test" (LTT) suggested that it was less often positive in Stevens-Johnson syndrome (SJS), Toxic Epidermal Necrolysis (TEN), than in other cutaneous reactions, with possible dependence on sampling date. We explored the possible role of inhibitory co-receptors in LTT, using well-defined groups of patients who reacted to carbamazepine (CBZ), or lamotrigine (LTG), sulfamethoxazole (SMX) and allopurinol (ALL).
Thirty one cases of SJS/TEN, and controls patients with DRESS (21) or exposed without reaction (EWR; (20)) were provided by the RegiSCAR group. Peripheral mononuclear cells (PBMC) were tested by qRT-PCR for the expression of the inhibitory co-receptors and their respective ligands : PD-1/PDL1, CTLA4/B7.1. LTT was performed with PBMCs by measuring H3-thymidine incorporation after 6 days incubation with CBZ/LTG/ALL (10µg/ml), SMX (50µg/ml) or medium, in the presence or not of blocking antibodies. Stimulation index ≥ 2.5 was considered positive. Mann-Whitney U test was used for comparison of gene expression level. A p value ≤0.05 was considered statistically significant.
Positive LTT was observed in 3/23 (13%) SJS/TEN and in 2/18 (11%) DRESS tested during the acute phase, and 7/22 (32%) SJS/TEN and 4/12 (33%) DRESS tested after recovery (late). LTT were all negative in EWR. As compared to their expression in PBMC of EWR, i) overexpression of CTLA4 and of B7.1 was found in acute and late SJS/TEN, respectively; ii) overexpression of PD-1 and PDL1 was found in acute DRESS. Combined addition of anti-CTLA4 and anti-PDL1 mAbs to LTT cultures of SJS/TEN (2 CBZ and 2 SMX) and DRESS (4 CBZ) increased drug-induced proliferation index, even turning some negative LTT into positive LTT (4 out of 8; 50%).
We confirm that reactive T cells are rarely detected in acute phase of SCAR, and to a lesser extent after recovery. We show for the first time that CTLA4- and PD-1 pathways are active in SJS/TEN and DRESS, respectively, and may contribute to the negative reactivity of LTT. The use of anti-CTLA4 and anti-PDL1 mAbs could help to sensitize drug-specific LTT.
Rights and permissions
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Valeyrie-Allanore, L., Mockenhaupt, M., Sekula, P. et al. Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients. Clin Transl Allergy 4 (Suppl 3), O1 (2014). https://doi.org/10.1186/2045-7022-4-S3-O1
- Toxic Epidermal Necrolysis